Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Adult T-cell Leukemia/Lymphoma (ATLL) is a rare and aggressive form of non-Hodgkin lymphoma that affects T-cells, a type of white blood cell. This malignancy is directly caused by infection with the Human T-cell Lymphotropic Virus Type I (HTLV-I). Blood testing plays a crucial role in diagnosing ATLL by detecting the underlying viral infection.
This comprehensive test detects antibodies against HTLV-I and HTLV-II in the blood, which is fundamental for ATLL diagnosis. Since ATLL is caused by HTLV-I infection, the presence of these antibodies confirms the underlying viral cause of this aggressive lymphoma. The test includes both preliminary screening and confirmation testing to ensure accurate results.
ATLL develops only in individuals who have been infected with HTLV-I, though not all people with HTLV-I will develop ATLL. The virus transforms normal T-cells into malignant cells, leading to the development of leukemia or lymphoma. Testing for HTLV-I/II antibodies is therefore essential for diagnosing and understanding this condition.
ATLL presents in several forms, ranging from indolent (slow-growing) to highly aggressive variants. Regardless of the subtype, all cases are associated with HTLV-I infection, making antibody testing a cornerstone of diagnosis. Additional blood tests may be needed to assess disease progression, organ function, and treatment response.
The information here is for educational purposes only and is not a substitute for professional medical advice. ATLL is a complex condition requiring specialized hematologic-oncologic care. Always consult with a healthcare provider for proper diagnosis, staging, and treatment planning.